Prolife Industries（PROLIFE）株式概要プロライフ・インダストリーズ社は、染料、顔料、医薬品、農薬などのナフタレン系中間体をインド国内外で製造・販売している。 詳細PROLIFE ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性5/6配当金2/6報酬株価収益率（ 7.7 x） Indian市場（ 23.8 x）を下回っています。リスク分析意味のある時価総額がありません ( ₹326M )過去5年間で収益は年間3.3%減少しました。 高いレベルの非現金収入 0.38%の配当はフリーキャッシュフローで十分にカバーされていない +1 さらなるリスクすべてのリスクチェックを見るPROLIFE Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW494,214 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINROAG494,214 investors already sharing narrativesYour Fair Value₹Current Price₹79.55182.3% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture0783m2016201920222025202620282031Revenue ₹349.9mEarnings ₹27.3mAdvancedSet Fair ValueView all narrativesProlife Industries Limited 競合他社Unilex Colours and ChemicalsSymbol: NSEI:UNILEXMarket cap: ₹381.3mGujarat PetrosyntheseSymbol: BSE:506858Market cap: ₹334.3mCamexSymbol: BSE:524440Market cap: ₹396.0mHaryana Leather ChemicalsSymbol: BSE:524080Market cap: ₹303.1m価格と性能株価の高値、安値、推移の概要Prolife Industries過去の株価現在の株価₹79.5552週高値₹156.7052週安値₹56.05ベータ-0.281ヶ月の変化26.67%3ヶ月変化34.15%1年変化-49.23%3年間の変化-65.82%5年間の変化-21.08%IPOからの変化114.42%最新ニュースValuation Update With 7 Day Price Move • Jun 26Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹75.80, the stock trades at a trailing P/E ratio of 7.3x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 69% over the past three years.New Risk • Jun 01New major risk - Revenue and earnings growthEarnings have declined by 3.3% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 3.3% per year over the past 5 years. High level of non-cash earnings (21% accrual ratio). Market cap is less than US$10m (₹233.4m market cap, or US$2.46m). Minor Risk Paying a dividend despite having no free cash flows.Reported Earnings • Jun 01Full year 2026 earnings released: EPS: ₹10.39 (vs ₹11.43 in FY 2025)Full year 2026 results: EPS: ₹10.39 (down from ₹11.43 in FY 2025). Revenue: ₹573.6m (up 3.4% from FY 2025). Net income: ₹42.5m (down 9.1% from FY 2025). Profit margin: 7.4% (down from 8.4% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has fallen by 39% per year, which means it is performing significantly worse than earnings.お知らせ • May 23Prolife Industries Limited to Report Second Half, 2026 Results on May 29, 2026Prolife Industries Limited announced that they will report second half, 2026 results on May 29, 2026Valuation Update With 7 Day Price Move • Apr 22Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹69.35, the stock trades at a trailing P/E ratio of 11.8x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 65% over the past three years.Valuation Update With 7 Day Price Move • Feb 27Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹60.15, the stock trades at a trailing P/E ratio of 10.2x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 71% over the past three years.最新情報をもっと見るRecent updatesValuation Update With 7 Day Price Move • Jun 26Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹75.80, the stock trades at a trailing P/E ratio of 7.3x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 69% over the past three years.New Risk • Jun 01New major risk - Revenue and earnings growthEarnings have declined by 3.3% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 3.3% per year over the past 5 years. High level of non-cash earnings (21% accrual ratio). Market cap is less than US$10m (₹233.4m market cap, or US$2.46m). Minor Risk Paying a dividend despite having no free cash flows.Reported Earnings • Jun 01Full year 2026 earnings released: EPS: ₹10.39 (vs ₹11.43 in FY 2025)Full year 2026 results: EPS: ₹10.39 (down from ₹11.43 in FY 2025). Revenue: ₹573.6m (up 3.4% from FY 2025). Net income: ₹42.5m (down 9.1% from FY 2025). Profit margin: 7.4% (down from 8.4% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has fallen by 39% per year, which means it is performing significantly worse than earnings.お知らせ • May 23Prolife Industries Limited to Report Second Half, 2026 Results on May 29, 2026Prolife Industries Limited announced that they will report second half, 2026 results on May 29, 2026Valuation Update With 7 Day Price Move • Apr 22Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹69.35, the stock trades at a trailing P/E ratio of 11.8x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 65% over the past three years.Valuation Update With 7 Day Price Move • Feb 27Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹60.15, the stock trades at a trailing P/E ratio of 10.2x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 71% over the past three years.Valuation Update With 7 Day Price Move • Feb 11Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹70.10, the stock trades at a trailing P/E ratio of 11.9x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 72% over the past year.New Risk • Jan 17New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$10m (₹274.3m market cap, or US$3.02m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (4.2% net profit margin).Valuation Update With 7 Day Price Move • Jan 05Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹67.00, the stock trades at a trailing P/E ratio of 11.4x. Average trailing P/E is 24x in the Chemicals industry in India. Total loss to shareholders of 70% over the past three years.分析記事 • Jan 01Lacklustre Performance Is Driving Prolife Industries Limited's (NSE:PROLIFE) Low P/EWith a price-to-earnings (or "P/E") ratio of 12.4x Prolife Industries Limited ( NSE:PROLIFE ) may be sending very...New Risk • Dec 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$10m (₹334.5m market cap, or US$3.74m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (4.2% net profit margin).Valuation Update With 7 Day Price Move • Nov 19Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹80.00, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 52% over the past three years.お知らせ • Nov 13Prolife Industries Limited to Report First Half, 2026 Results on Nov 14, 2025Prolife Industries Limited announced that they will report first half, 2026 results on Nov 14, 2025Board Change • Nov 11Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Executive Director Siddharth Raghuvanshi was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Valuation Update With 7 Day Price Move • Sep 10Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹107, the stock trades at a trailing P/E ratio of 9.3x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 30% over the past three years.分析記事 • Sep 10Little Excitement Around Prolife Industries Limited's (NSE:PROLIFE) Earnings As Shares Take 25% PoundingThe Prolife Industries Limited ( NSE:PROLIFE ) share price has fared very poorly over the last month, falling by a...Upcoming Dividend • Sep 09Upcoming dividend of ₹0.30 per shareEligible shareholders must have bought the stock before 16 September 2025. Payment date: 23 October 2025. Payout ratio is a comfortable 2.6% but the company is not cash flow positive. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.3%). Lower than average of industry peers (0.7%).分析記事 • Aug 25Prolife Industries (NSE:PROLIFE) Has Announced That Its Dividend Will Be Reduced To ₹0.30Prolife Industries Limited's ( NSE:PROLIFE ) dividend is being reduced by 40% to ₹0.30 per share on 23rd of October, in...Declared Dividend • Aug 25Dividend reduced to ₹0.30Dividend of ₹0.30 is 40% lower than last year. Ex-date: 16th September 2025 Payment date: 23rd October 2025 Dividend yield will be 0.2%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (3% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 12% per year over the past 8 years and payments have been stable during that time. Earnings per share has grown by 3.0% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Aug 23Prolife Industries Limited announces Annual dividend, payable on October 23, 2025Prolife Industries Limited announced Annual dividend of INR 0.3000 per share payable on October 23, 2025, ex-date on September 16, 2025 and record date on September 16, 2025.お知らせ • Aug 22Prolife Industries Limited, Annual General Meeting, Sep 23, 2025Prolife Industries Limited, Annual General Meeting, Sep 23, 2025, at 09:00 Indian Standard Time. Location: 6,8,10,12 hexzone arcade, nr. jayaben modi hospital, valia rd., g.i.d.c., gujarat - 393002., anleshwar IndiaNew Risk • Jun 27New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 8.1% Last year net profit margin: 15% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (23% accrual ratio). Market cap is less than US$10m (₹646.9m market cap, or US$7.56m). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (8.1% net profit margin).New Risk • Jun 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (23% accrual ratio). Market cap is less than US$10m (₹634.6m market cap, or US$7.40m). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.0% average weekly change).Valuation Update With 7 Day Price Move • Jun 04Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹146, the stock trades at a trailing P/E ratio of 7.9x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 11% over the past three years.New Risk • Jun 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (23% accrual ratio). Market cap is less than US$10m (₹678.8m market cap, or US$7.95m). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Paying a dividend despite having no free cash flows.分析記事 • May 14Lacklustre Performance Is Driving Prolife Industries Limited's (NSE:PROLIFE) 25% Price DropUnfortunately for some shareholders, the Prolife Industries Limited ( NSE:PROLIFE ) share price has dived 25% in the...New Risk • May 09New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 0.3% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (23% accrual ratio). Market cap is less than US$10m (₹704.4m market cap, or US$8.21m). Minor Risk Paying a dividend despite having no free cash flows.分析記事 • Mar 13Benign Growth For Prolife Industries Limited (NSE:PROLIFE) Underpins Stock's 25% PlummetProlife Industries Limited ( NSE:PROLIFE ) shareholders that were waiting for something to happen have been dealt a...New Risk • Mar 10New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹873.3m (US$10.00m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.8% average weekly change). High level of non-cash earnings (23% accrual ratio). Market cap is less than US$10m (₹873.3m market cap, or US$10.00m).Valuation Update With 7 Day Price Move • Jan 14Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₹268, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 60% over the past three years.分析記事 • Jan 07Prolife Industries Limited's (NSE:PROLIFE) Share Price Boosted 25% But Its Business Prospects Need A Lift TooDespite an already strong run, Prolife Industries Limited ( NSE:PROLIFE ) shares have been powering on, with a gain of...Valuation Update With 7 Day Price Move • Dec 30Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹318, the stock trades at a trailing P/E ratio of 17.2x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 119% over the past three years.Valuation Update With 7 Day Price Move • Nov 28Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹299, the stock trades at a trailing P/E ratio of 16.2x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 149% over the past three years.New Risk • Nov 16New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 23% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (23% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.20b market cap, or US$14.2m).Valuation Update With 7 Day Price Move • Nov 08Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹296, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 143% over the past three years.分析記事 • Oct 21Improved Earnings Required Before Prolife Industries Limited (NSE:PROLIFE) Stock's 27% Jump Looks JustifiedProlife Industries Limited ( NSE:PROLIFE ) shares have continued their recent momentum with a 27% gain in the last...Valuation Update With 7 Day Price Move • Oct 10Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹255, the stock trades at a trailing P/E ratio of 11.9x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 147% over the past three years.お知らせ • Sep 24Prolife Industries Limited Approves Final Dividend for the Financial Year 2023-24Prolife Industries Limited at its AGM held on September 23, 2024 approved final dividend of INR 0.50 per shares on Equity shares of face value INR 10/- for the financial year 2023-24.Upcoming Dividend • Sep 11Upcoming dividend of ₹0.50 per shareEligible shareholders must have bought the stock before 16 September 2024. Payment date: 23 October 2024. Payout ratio is a comfortable 2.3% and this is well supported by cash flows. Trailing yield: 0.2%. Lower than top quartile of Indian dividend payers (1.0%). Lower than average of industry peers (0.6%).Valuation Update With 7 Day Price Move • Sep 04Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹249, the stock trades at a trailing P/E ratio of 11.6x. Average trailing P/E is 36x in the Chemicals industry in India. Total returns to shareholders of 177% over the past three years.New Risk • Aug 29New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹838.1m (US$9.99m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company.Declared Dividend • Aug 28Dividend of ₹0.50 announcedShareholders will receive a dividend of ₹0.50. Ex-date: 16th September 2024 Payment date: 23rd October 2024 Dividend yield will be 0.2%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (1% earnings payout ratio) and cash flows (0.7587% cash payout ratio). The dividend has increased by an average of 6.0% per year over the past 7 years and payments have been stable during that time. Earnings per share has grown by 34% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Aug 26Prolife Industries Limited, Annual General Meeting, Sep 23, 2024Prolife Industries Limited, Annual General Meeting, Sep 23, 2024, at 09:00 Indian Standard Time. Location: 6,8,10,12 hexzone arcade, nr. jayaben modi hospital, valia rd., g.i.d.c., anleshwar- 393002., India分析記事 • Aug 06There's No Escaping Prolife Industries Limited's (NSE:PROLIFE) Muted Earnings Despite A 26% Share Price RiseProlife Industries Limited ( NSE:PROLIFE ) shares have had a really impressive month, gaining 26% after a shaky period...New Risk • Aug 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Market cap is less than US$100m (₹1.03b market cap, or US$12.3m).分析記事 • Aug 02Here's Why Prolife Industries (NSE:PROLIFE) Has Caught The Eye Of InvestorsInvestors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Valuation Update With 7 Day Price Move • Aug 01Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹241, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 136% over the past three years.分析記事 • Jun 06We Think Prolife Industries' (NSE:PROLIFE) Healthy Earnings Might Be ConservativeThe market seemed underwhelmed by last week's earnings announcement from Prolife Industries Limited ( NSE:PROLIFE...Reported Earnings • Jun 04Full year 2024 earnings released: EPS: ₹21.40 (vs ₹16.89 in FY 2023)Full year 2024 results: EPS: ₹21.40 (up from ₹16.89 in FY 2023). Revenue: ₹584.2m (down 25% from FY 2023). Net income: ₹87.6m (up 27% from FY 2023). Profit margin: 15% (up from 8.8% in FY 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 26% per year.New Risk • May 21New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Share price has been volatile over the past 3 months (8.0% average weekly change). Market cap is less than US$100m (₹851.6m market cap, or US$10.2m).Valuation Update With 7 Day Price Move • Mar 15Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹220, the stock trades at a trailing P/E ratio of 10.7x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 315% over the past three years.分析記事 • Mar 15Here's Why Prolife Industries (NSE:PROLIFE) Has Caught The Eye Of InvestorsInvestors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...分析記事 • Jan 20Prolife Industries Limited (NSE:PROLIFE) Surges 32% Yet Its Low P/E Is No Reason For ExcitementDespite an already strong run, Prolife Industries Limited ( NSE:PROLIFE ) shares have been powering on, with a gain of...Valuation Update With 7 Day Price Move • Jan 12Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹286, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 365% over the past three years.Board Change • Dec 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Executive Director Siddharth Raghuvanshi was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.分析記事 • Nov 11Prolife Industries' (NSE:PROLIFE) Earnings Offer More Than Meets The EyeProlife Industries Limited's ( NSE:PROLIFE ) recent earnings report didn't offer any surprises, with the shares...Valuation Update With 7 Day Price Move • Nov 10Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹255, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 552% over the past three years.New Risk • Oct 25New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹812.7m (US$9.77m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (26% accrual ratio). Market cap is less than US$10m (₹812.7m market cap, or US$9.77m).Upcoming Dividend • Sep 06Upcoming dividend of ₹0.30 per share at 0.1% yieldEligible shareholders must have bought the stock before 13 September 2023. Payment date: 20 October 2023. Payout ratio is a comfortable 1.8% but the company is not cash flow positive. Trailing yield: 0.1%. Lower than top quartile of Indian dividend payers (1.3%). Lower than average of industry peers (0.8%).お知らせ • Aug 25Prolife Industries Limited, Annual General Meeting, Sep 20, 2023Prolife Industries Limited, Annual General Meeting, Sep 20, 2023, at 09:00 Indian Standard Time. Location: 6,8,10,12 HEXZONE ARCADE NR. JAYABEN MODI HOSPITAL, VALIA ROAD, G.I.D.C. ANKLESHWAR- 393002 Ankleshwar India Agenda: To consider and approve the Audited Financial Statements of the Company for the financial year ended March 31, 2023, together with the Reports of the Board of Directors and the Auditors thereon; to consider and approve the appointment of a Director in place of Mrs. Anureet Kaur M Jolly who retires by rotation in terms of section 152(6) of the Companies Act, 2013 and being eligible to offer herself for re-appointment; and to consider other matters.Valuation Update With 7 Day Price Move • Jul 17Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹245, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 704% over the past three years.Valuation Update With 7 Day Price Move • Jun 07Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹229, the stock trades at a trailing P/E ratio of 13.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 39% over the past year.Reported Earnings • Jun 01Full year 2023 earnings released: EPS: ₹16.89 (vs ₹10.51 in FY 2022)Full year 2023 results: EPS: ₹16.89 (up from ₹10.51 in FY 2022). Revenue: ₹805.0m (up 10.0% from FY 2022). Net income: ₹69.1m (up 61% from FY 2022). Profit margin: 8.6% (up from 5.9% in FY 2022). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • May 18Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹243, the stock trades at a trailing P/E ratio of 20.4x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 47% over the past year.Valuation Update With 7 Day Price Move • Dec 16Investor sentiment improved over the past weekAfter last week's 24% share price gain to ₹202, the stock trades at a trailing P/E ratio of 16.9x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 598% over the past three years.Reported Earnings • Nov 16First half 2023 earnings released: EPS: ₹8.43 (vs ₹7.01 in 1H 2022)First half 2023 results: EPS: ₹8.43 (up from ₹7.01 in 1H 2022). Revenue: ₹438.1m (up 24% from 1H 2022). Net income: ₹34.5m (up 20% from 1H 2022). Profit margin: 7.9% (down from 8.1% in 1H 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 84% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Sep 10Full year 2022 earnings released: EPS: ₹10.51 (vs ₹13.43 in FY 2021)Full year 2022 results: EPS: ₹10.51 (down from ₹13.43 in FY 2021). Revenue: ₹732.0m (flat on FY 2021). Net income: ₹43.0m (down 22% from FY 2021). Profit margin: 5.9% (down from 7.5% in FY 2021). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has increased by 86% per year, which means it is tracking significantly ahead of earnings growth.Board Change • May 31High number of new directorsExecutive Director Siddharth Raghuvanshi was the last director to join the board, commencing their role in 2020.分析記事 • May 24With EPS Growth And More, Prolife Industries (NSE:PROLIFE) Is InterestingLike a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...Board Change • Apr 27High number of new directorsExecutive Director Siddharth Raghuvanshi was the last director to join the board, commencing their role in 2020.Valuation Update With 7 Day Price Move • Feb 08Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₹156, the stock trades at a trailing P/E ratio of 11.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 470% over the past three years.Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹182, the stock trades at a trailing P/E ratio of 13.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 503% over the past three years.Valuation Update With 7 Day Price Move • Dec 28Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹130, the stock trades at a trailing P/E ratio of 9.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 125% over the past year.分析記事 • Dec 07Here's Why I Think Prolife Industries (NSE:PROLIFE) Is An Interesting StockLike a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...Valuation Update With 7 Day Price Move • Nov 01Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹120, the stock trades at a trailing P/E ratio of 8.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 309% over the past three years.Board Change • Nov 01High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Chairman & MD Karan Jolly was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Board Change • Oct 15High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Chairman & MD Karan Jolly was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Upcoming Dividend • Sep 15Upcoming dividend of ₹0.30 per shareEligible shareholders must have bought the stock before 22 September 2021. Payment date: 29 October 2021. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.7%).Executive Departure • Sep 11Company Secretary & Compliance Officer Darshna Maniyar has left the companyOn the 3rd of September, Darshna Maniyar's tenure as Company Secretary & Compliance Officer ended after 5.0 years in the role. We don't have any record of a personal shareholding under Darshna's name. Darshna is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 5.08 years.Valuation Update With 7 Day Price Move • Aug 20Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹101, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 266% over the past three years.Valuation Update With 7 Day Price Move • Jul 19Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹101, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 249% over the past three years.Valuation Update With 7 Day Price Move • May 30Investor sentiment improved over the past weekAfter last week's 28% share price gain to ₹70.65, the stock trades at a trailing P/E ratio of 5.3x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 118% over the past three years.Valuation Update With 7 Day Price Move • May 14Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹48.80, the stock trades at a trailing P/E ratio of 3.7x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 65% over the past three years.分析記事 • May 10Prolife Industries Limited's (NSE:PROLIFE) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?Could Prolife Industries Limited ( NSE:PROLIFE ) be an attractive dividend share to own for the long haul? Investors...分析記事 • Mar 15Prolife Industries Limited's (NSE:PROLIFE) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?Prolife Industries (NSE:PROLIFE) has had a rough month with its share price down 17%. However, stock prices are usually...分析記事 • Feb 07Is It Worth Buying Prolife Industries Limited (NSE:PROLIFE) For Its 0.5% Dividend Yield?Today we'll take a closer look at Prolife Industries Limited ( NSE:PROLIFE ) from a dividend investor's perspective...Valuation Update With 7 Day Price Move • Jan 08Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹64.75, the stock is trading at a trailing P/E ratio of 4.9x, up from the previous P/E ratio of 4.2x. This compares to an average P/E of 19x in the Chemicals industry in India. Total returns to shareholders over the past three years are 90%.分析記事 • Jan 03Should You Be Adding Prolife Industries (NSE:PROLIFE) To Your Watchlist Today?Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...Valuation Update With 7 Day Price Move • Dec 18Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹63.50, the stock is trading at a trailing P/E ratio of 4.8x, up from the previous P/E ratio of 4x. This compares to an average P/E of 18x in the Chemicals industry in India. Total returns to shareholders over the past three years are 91%.Valuation Update With 7 Day Price Move • Dec 02Market bids up stock over the past weekAfter last week's 16% share price gain to ₹43.35, the stock is trading at a trailing P/E ratio of 3.3x, up from the previous P/E ratio of 2.8x. This compares to an average P/E of 16x in the Chemicals industry in India. Total returns to shareholders over the past three years are 12%.分析記事 • Nov 29Prolife Industries Limited's (NSE:PROLIFE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?Most readers would already be aware that Prolife Industries' (NSE:PROLIFE) stock increased significantly by 18% over...株主還元PROLIFEIN ChemicalsIN 市場7D0%-1.0%0.3%1Y-49.2%-4.0%-0.09%株主還元を見る業界別リターン: PROLIFE過去 1 年間で-4 % の収益を上げたIndian Chemicals業界を下回りました。リターン対市場: PROLIFEは、過去 1 年間で-0.1 % のリターンを上げたIndian市場を下回りました。価格変動Is PROLIFE's price volatile compared to industry and market?PROLIFE volatilityPROLIFE Average Weekly Movement8.9%Chemicals Industry Average Movement6.1%Market Average Movement6.2%10% most volatile stocks in IN Market9.1%10% least volatile stocks in IN Market3.9%安定した株価: PROLIFEの株価は、 Indian市場と比較して過去 3 か月間で変動しています。時間の経過による変動: PROLIFEの weekly volatility ( 9% ) は過去 1 年間安定していますが、依然としてIndianの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト199466Karan Jollywww.prolifeindustries.inProlife Industries Limited は、染料、顔料、医薬品、農薬などに使用されるナフタレン系中間体をインド国内外で製造・販売している。ジヒドロチオパラトルイジンスルホン酸、アミノフェノキシプロパンスルホン酸、アミノメチルフェノキシスルホン酸、2-クロロメチル-3,4-ジメトキシピリジン、オクタヒドロ-4b-メチル-9、ジアミノビスフェノキシエタン、5-メトキシ6-アミノベンズイミダゾール、塩基性染料、PYBIZSなどを提供している。また、米国、スペイン、スイス、ドイツ、フランス、台湾、日本、ブラジル、パキスタンなどに製品を輸出している。旧社名はRRJ Dyes and Intermediates Limitedで、2013年3月に社名をProlife Industries Limitedに変更した。プロライフ・インダストリーズ・リミテッドは1994年に法人化され、インドのアンクレシュワルに本社を置いている。もっと見るProlife Industries Limited 基礎のまとめProlife Industries の収益と売上を時価総額と比較するとどうか。PROLIFE 基礎統計学時価総額₹325.68m収益（TTM）₹42.54m売上高(TTM)₹545.23m7.7xPER（株価収益率0.6xP/SレシオPROLIFE は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計PROLIFE 損益計算書（TTM）収益₹545.23m売上原価₹355.30m売上総利益₹189.93mその他の費用₹147.39m収益₹42.54m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）10.39グロス・マージン34.84%純利益率7.80%有利子負債／自己資本比率0.6%PROLIFE の長期的なパフォーマンスは？過去の実績と比較を見る配当金0.4%現在の配当利回り3%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/13 18:29終値2026/07/13 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Prolife Industries Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Valuation Update With 7 Day Price Move • Jun 26Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹75.80, the stock trades at a trailing P/E ratio of 7.3x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 69% over the past three years.
New Risk • Jun 01New major risk - Revenue and earnings growthEarnings have declined by 3.3% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 3.3% per year over the past 5 years. High level of non-cash earnings (21% accrual ratio). Market cap is less than US$10m (₹233.4m market cap, or US$2.46m). Minor Risk Paying a dividend despite having no free cash flows.
Reported Earnings • Jun 01Full year 2026 earnings released: EPS: ₹10.39 (vs ₹11.43 in FY 2025)Full year 2026 results: EPS: ₹10.39 (down from ₹11.43 in FY 2025). Revenue: ₹573.6m (up 3.4% from FY 2025). Net income: ₹42.5m (down 9.1% from FY 2025). Profit margin: 7.4% (down from 8.4% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has fallen by 39% per year, which means it is performing significantly worse than earnings.
お知らせ • May 23Prolife Industries Limited to Report Second Half, 2026 Results on May 29, 2026Prolife Industries Limited announced that they will report second half, 2026 results on May 29, 2026
Valuation Update With 7 Day Price Move • Apr 22Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹69.35, the stock trades at a trailing P/E ratio of 11.8x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 65% over the past three years.
Valuation Update With 7 Day Price Move • Feb 27Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹60.15, the stock trades at a trailing P/E ratio of 10.2x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 71% over the past three years.
Valuation Update With 7 Day Price Move • Jun 26Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹75.80, the stock trades at a trailing P/E ratio of 7.3x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 69% over the past three years.
New Risk • Jun 01New major risk - Revenue and earnings growthEarnings have declined by 3.3% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 3.3% per year over the past 5 years. High level of non-cash earnings (21% accrual ratio). Market cap is less than US$10m (₹233.4m market cap, or US$2.46m). Minor Risk Paying a dividend despite having no free cash flows.
Reported Earnings • Jun 01Full year 2026 earnings released: EPS: ₹10.39 (vs ₹11.43 in FY 2025)Full year 2026 results: EPS: ₹10.39 (down from ₹11.43 in FY 2025). Revenue: ₹573.6m (up 3.4% from FY 2025). Net income: ₹42.5m (down 9.1% from FY 2025). Profit margin: 7.4% (down from 8.4% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has fallen by 39% per year, which means it is performing significantly worse than earnings.
お知らせ • May 23Prolife Industries Limited to Report Second Half, 2026 Results on May 29, 2026Prolife Industries Limited announced that they will report second half, 2026 results on May 29, 2026
Valuation Update With 7 Day Price Move • Apr 22Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹69.35, the stock trades at a trailing P/E ratio of 11.8x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 65% over the past three years.
Valuation Update With 7 Day Price Move • Feb 27Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹60.15, the stock trades at a trailing P/E ratio of 10.2x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 71% over the past three years.
Valuation Update With 7 Day Price Move • Feb 11Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹70.10, the stock trades at a trailing P/E ratio of 11.9x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 72% over the past year.
New Risk • Jan 17New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$10m (₹274.3m market cap, or US$3.02m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (4.2% net profit margin).
Valuation Update With 7 Day Price Move • Jan 05Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹67.00, the stock trades at a trailing P/E ratio of 11.4x. Average trailing P/E is 24x in the Chemicals industry in India. Total loss to shareholders of 70% over the past three years.
分析記事 • Jan 01Lacklustre Performance Is Driving Prolife Industries Limited's (NSE:PROLIFE) Low P/EWith a price-to-earnings (or "P/E") ratio of 12.4x Prolife Industries Limited ( NSE:PROLIFE ) may be sending very...
New Risk • Dec 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$10m (₹334.5m market cap, or US$3.74m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (4.2% net profit margin).
Valuation Update With 7 Day Price Move • Nov 19Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹80.00, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 52% over the past three years.
お知らせ • Nov 13Prolife Industries Limited to Report First Half, 2026 Results on Nov 14, 2025Prolife Industries Limited announced that they will report first half, 2026 results on Nov 14, 2025
Board Change • Nov 11Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Executive Director Siddharth Raghuvanshi was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Sep 10Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹107, the stock trades at a trailing P/E ratio of 9.3x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 30% over the past three years.
分析記事 • Sep 10Little Excitement Around Prolife Industries Limited's (NSE:PROLIFE) Earnings As Shares Take 25% PoundingThe Prolife Industries Limited ( NSE:PROLIFE ) share price has fared very poorly over the last month, falling by a...
Upcoming Dividend • Sep 09Upcoming dividend of ₹0.30 per shareEligible shareholders must have bought the stock before 16 September 2025. Payment date: 23 October 2025. Payout ratio is a comfortable 2.6% but the company is not cash flow positive. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.3%). Lower than average of industry peers (0.7%).
分析記事 • Aug 25Prolife Industries (NSE:PROLIFE) Has Announced That Its Dividend Will Be Reduced To ₹0.30Prolife Industries Limited's ( NSE:PROLIFE ) dividend is being reduced by 40% to ₹0.30 per share on 23rd of October, in...
Declared Dividend • Aug 25Dividend reduced to ₹0.30Dividend of ₹0.30 is 40% lower than last year. Ex-date: 16th September 2025 Payment date: 23rd October 2025 Dividend yield will be 0.2%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (3% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 12% per year over the past 8 years and payments have been stable during that time. Earnings per share has grown by 3.0% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Aug 23Prolife Industries Limited announces Annual dividend, payable on October 23, 2025Prolife Industries Limited announced Annual dividend of INR 0.3000 per share payable on October 23, 2025, ex-date on September 16, 2025 and record date on September 16, 2025.
お知らせ • Aug 22Prolife Industries Limited, Annual General Meeting, Sep 23, 2025Prolife Industries Limited, Annual General Meeting, Sep 23, 2025, at 09:00 Indian Standard Time. Location: 6,8,10,12 hexzone arcade, nr. jayaben modi hospital, valia rd., g.i.d.c., gujarat - 393002., anleshwar India
New Risk • Jun 27New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 8.1% Last year net profit margin: 15% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (23% accrual ratio). Market cap is less than US$10m (₹646.9m market cap, or US$7.56m). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (8.1% net profit margin).
New Risk • Jun 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (23% accrual ratio). Market cap is less than US$10m (₹634.6m market cap, or US$7.40m). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.0% average weekly change).
Valuation Update With 7 Day Price Move • Jun 04Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹146, the stock trades at a trailing P/E ratio of 7.9x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 11% over the past three years.
New Risk • Jun 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (23% accrual ratio). Market cap is less than US$10m (₹678.8m market cap, or US$7.95m). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Paying a dividend despite having no free cash flows.
分析記事 • May 14Lacklustre Performance Is Driving Prolife Industries Limited's (NSE:PROLIFE) 25% Price DropUnfortunately for some shareholders, the Prolife Industries Limited ( NSE:PROLIFE ) share price has dived 25% in the...
New Risk • May 09New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 0.3% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (23% accrual ratio). Market cap is less than US$10m (₹704.4m market cap, or US$8.21m). Minor Risk Paying a dividend despite having no free cash flows.
分析記事 • Mar 13Benign Growth For Prolife Industries Limited (NSE:PROLIFE) Underpins Stock's 25% PlummetProlife Industries Limited ( NSE:PROLIFE ) shareholders that were waiting for something to happen have been dealt a...
New Risk • Mar 10New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹873.3m (US$10.00m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.8% average weekly change). High level of non-cash earnings (23% accrual ratio). Market cap is less than US$10m (₹873.3m market cap, or US$10.00m).
Valuation Update With 7 Day Price Move • Jan 14Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₹268, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 60% over the past three years.
分析記事 • Jan 07Prolife Industries Limited's (NSE:PROLIFE) Share Price Boosted 25% But Its Business Prospects Need A Lift TooDespite an already strong run, Prolife Industries Limited ( NSE:PROLIFE ) shares have been powering on, with a gain of...
Valuation Update With 7 Day Price Move • Dec 30Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹318, the stock trades at a trailing P/E ratio of 17.2x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 119% over the past three years.
Valuation Update With 7 Day Price Move • Nov 28Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹299, the stock trades at a trailing P/E ratio of 16.2x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 149% over the past three years.
New Risk • Nov 16New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 23% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (23% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.20b market cap, or US$14.2m).
Valuation Update With 7 Day Price Move • Nov 08Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹296, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 143% over the past three years.
分析記事 • Oct 21Improved Earnings Required Before Prolife Industries Limited (NSE:PROLIFE) Stock's 27% Jump Looks JustifiedProlife Industries Limited ( NSE:PROLIFE ) shares have continued their recent momentum with a 27% gain in the last...
Valuation Update With 7 Day Price Move • Oct 10Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹255, the stock trades at a trailing P/E ratio of 11.9x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 147% over the past three years.
お知らせ • Sep 24Prolife Industries Limited Approves Final Dividend for the Financial Year 2023-24Prolife Industries Limited at its AGM held on September 23, 2024 approved final dividend of INR 0.50 per shares on Equity shares of face value INR 10/- for the financial year 2023-24.
Upcoming Dividend • Sep 11Upcoming dividend of ₹0.50 per shareEligible shareholders must have bought the stock before 16 September 2024. Payment date: 23 October 2024. Payout ratio is a comfortable 2.3% and this is well supported by cash flows. Trailing yield: 0.2%. Lower than top quartile of Indian dividend payers (1.0%). Lower than average of industry peers (0.6%).
Valuation Update With 7 Day Price Move • Sep 04Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹249, the stock trades at a trailing P/E ratio of 11.6x. Average trailing P/E is 36x in the Chemicals industry in India. Total returns to shareholders of 177% over the past three years.
New Risk • Aug 29New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹838.1m (US$9.99m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company.
Declared Dividend • Aug 28Dividend of ₹0.50 announcedShareholders will receive a dividend of ₹0.50. Ex-date: 16th September 2024 Payment date: 23rd October 2024 Dividend yield will be 0.2%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (1% earnings payout ratio) and cash flows (0.7587% cash payout ratio). The dividend has increased by an average of 6.0% per year over the past 7 years and payments have been stable during that time. Earnings per share has grown by 34% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Aug 26Prolife Industries Limited, Annual General Meeting, Sep 23, 2024Prolife Industries Limited, Annual General Meeting, Sep 23, 2024, at 09:00 Indian Standard Time. Location: 6,8,10,12 hexzone arcade, nr. jayaben modi hospital, valia rd., g.i.d.c., anleshwar- 393002., India
分析記事 • Aug 06There's No Escaping Prolife Industries Limited's (NSE:PROLIFE) Muted Earnings Despite A 26% Share Price RiseProlife Industries Limited ( NSE:PROLIFE ) shares have had a really impressive month, gaining 26% after a shaky period...
New Risk • Aug 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Market cap is less than US$100m (₹1.03b market cap, or US$12.3m).
分析記事 • Aug 02Here's Why Prolife Industries (NSE:PROLIFE) Has Caught The Eye Of InvestorsInvestors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Valuation Update With 7 Day Price Move • Aug 01Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹241, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 136% over the past three years.
分析記事 • Jun 06We Think Prolife Industries' (NSE:PROLIFE) Healthy Earnings Might Be ConservativeThe market seemed underwhelmed by last week's earnings announcement from Prolife Industries Limited ( NSE:PROLIFE...
Reported Earnings • Jun 04Full year 2024 earnings released: EPS: ₹21.40 (vs ₹16.89 in FY 2023)Full year 2024 results: EPS: ₹21.40 (up from ₹16.89 in FY 2023). Revenue: ₹584.2m (down 25% from FY 2023). Net income: ₹87.6m (up 27% from FY 2023). Profit margin: 15% (up from 8.8% in FY 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 26% per year.
New Risk • May 21New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Share price has been volatile over the past 3 months (8.0% average weekly change). Market cap is less than US$100m (₹851.6m market cap, or US$10.2m).
Valuation Update With 7 Day Price Move • Mar 15Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹220, the stock trades at a trailing P/E ratio of 10.7x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 315% over the past three years.
分析記事 • Mar 15Here's Why Prolife Industries (NSE:PROLIFE) Has Caught The Eye Of InvestorsInvestors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
分析記事 • Jan 20Prolife Industries Limited (NSE:PROLIFE) Surges 32% Yet Its Low P/E Is No Reason For ExcitementDespite an already strong run, Prolife Industries Limited ( NSE:PROLIFE ) shares have been powering on, with a gain of...
Valuation Update With 7 Day Price Move • Jan 12Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹286, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 365% over the past three years.
Board Change • Dec 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Executive Director Siddharth Raghuvanshi was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
分析記事 • Nov 11Prolife Industries' (NSE:PROLIFE) Earnings Offer More Than Meets The EyeProlife Industries Limited's ( NSE:PROLIFE ) recent earnings report didn't offer any surprises, with the shares...
Valuation Update With 7 Day Price Move • Nov 10Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹255, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 552% over the past three years.
New Risk • Oct 25New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹812.7m (US$9.77m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (26% accrual ratio). Market cap is less than US$10m (₹812.7m market cap, or US$9.77m).
Upcoming Dividend • Sep 06Upcoming dividend of ₹0.30 per share at 0.1% yieldEligible shareholders must have bought the stock before 13 September 2023. Payment date: 20 October 2023. Payout ratio is a comfortable 1.8% but the company is not cash flow positive. Trailing yield: 0.1%. Lower than top quartile of Indian dividend payers (1.3%). Lower than average of industry peers (0.8%).
お知らせ • Aug 25Prolife Industries Limited, Annual General Meeting, Sep 20, 2023Prolife Industries Limited, Annual General Meeting, Sep 20, 2023, at 09:00 Indian Standard Time. Location: 6,8,10,12 HEXZONE ARCADE NR. JAYABEN MODI HOSPITAL, VALIA ROAD, G.I.D.C. ANKLESHWAR- 393002 Ankleshwar India Agenda: To consider and approve the Audited Financial Statements of the Company for the financial year ended March 31, 2023, together with the Reports of the Board of Directors and the Auditors thereon; to consider and approve the appointment of a Director in place of Mrs. Anureet Kaur M Jolly who retires by rotation in terms of section 152(6) of the Companies Act, 2013 and being eligible to offer herself for re-appointment; and to consider other matters.
Valuation Update With 7 Day Price Move • Jul 17Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹245, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 704% over the past three years.
Valuation Update With 7 Day Price Move • Jun 07Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹229, the stock trades at a trailing P/E ratio of 13.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 39% over the past year.
Reported Earnings • Jun 01Full year 2023 earnings released: EPS: ₹16.89 (vs ₹10.51 in FY 2022)Full year 2023 results: EPS: ₹16.89 (up from ₹10.51 in FY 2022). Revenue: ₹805.0m (up 10.0% from FY 2022). Net income: ₹69.1m (up 61% from FY 2022). Profit margin: 8.6% (up from 5.9% in FY 2022). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • May 18Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹243, the stock trades at a trailing P/E ratio of 20.4x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 47% over the past year.
Valuation Update With 7 Day Price Move • Dec 16Investor sentiment improved over the past weekAfter last week's 24% share price gain to ₹202, the stock trades at a trailing P/E ratio of 16.9x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 598% over the past three years.
Reported Earnings • Nov 16First half 2023 earnings released: EPS: ₹8.43 (vs ₹7.01 in 1H 2022)First half 2023 results: EPS: ₹8.43 (up from ₹7.01 in 1H 2022). Revenue: ₹438.1m (up 24% from 1H 2022). Net income: ₹34.5m (up 20% from 1H 2022). Profit margin: 7.9% (down from 8.1% in 1H 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 84% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Sep 10Full year 2022 earnings released: EPS: ₹10.51 (vs ₹13.43 in FY 2021)Full year 2022 results: EPS: ₹10.51 (down from ₹13.43 in FY 2021). Revenue: ₹732.0m (flat on FY 2021). Net income: ₹43.0m (down 22% from FY 2021). Profit margin: 5.9% (down from 7.5% in FY 2021). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has increased by 86% per year, which means it is tracking significantly ahead of earnings growth.
Board Change • May 31High number of new directorsExecutive Director Siddharth Raghuvanshi was the last director to join the board, commencing their role in 2020.
分析記事 • May 24With EPS Growth And More, Prolife Industries (NSE:PROLIFE) Is InterestingLike a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Board Change • Apr 27High number of new directorsExecutive Director Siddharth Raghuvanshi was the last director to join the board, commencing their role in 2020.
Valuation Update With 7 Day Price Move • Feb 08Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₹156, the stock trades at a trailing P/E ratio of 11.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 470% over the past three years.
Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹182, the stock trades at a trailing P/E ratio of 13.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 503% over the past three years.
Valuation Update With 7 Day Price Move • Dec 28Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹130, the stock trades at a trailing P/E ratio of 9.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 125% over the past year.
分析記事 • Dec 07Here's Why I Think Prolife Industries (NSE:PROLIFE) Is An Interesting StockLike a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Valuation Update With 7 Day Price Move • Nov 01Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹120, the stock trades at a trailing P/E ratio of 8.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 309% over the past three years.
Board Change • Nov 01High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Chairman & MD Karan Jolly was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Board Change • Oct 15High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Chairman & MD Karan Jolly was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Upcoming Dividend • Sep 15Upcoming dividend of ₹0.30 per shareEligible shareholders must have bought the stock before 22 September 2021. Payment date: 29 October 2021. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.7%).
Executive Departure • Sep 11Company Secretary & Compliance Officer Darshna Maniyar has left the companyOn the 3rd of September, Darshna Maniyar's tenure as Company Secretary & Compliance Officer ended after 5.0 years in the role. We don't have any record of a personal shareholding under Darshna's name. Darshna is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 5.08 years.
Valuation Update With 7 Day Price Move • Aug 20Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹101, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 266% over the past three years.
Valuation Update With 7 Day Price Move • Jul 19Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹101, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 249% over the past three years.
Valuation Update With 7 Day Price Move • May 30Investor sentiment improved over the past weekAfter last week's 28% share price gain to ₹70.65, the stock trades at a trailing P/E ratio of 5.3x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 118% over the past three years.
Valuation Update With 7 Day Price Move • May 14Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹48.80, the stock trades at a trailing P/E ratio of 3.7x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 65% over the past three years.
分析記事 • May 10Prolife Industries Limited's (NSE:PROLIFE) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?Could Prolife Industries Limited ( NSE:PROLIFE ) be an attractive dividend share to own for the long haul? Investors...
分析記事 • Mar 15Prolife Industries Limited's (NSE:PROLIFE) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?Prolife Industries (NSE:PROLIFE) has had a rough month with its share price down 17%. However, stock prices are usually...
分析記事 • Feb 07Is It Worth Buying Prolife Industries Limited (NSE:PROLIFE) For Its 0.5% Dividend Yield?Today we'll take a closer look at Prolife Industries Limited ( NSE:PROLIFE ) from a dividend investor's perspective...
Valuation Update With 7 Day Price Move • Jan 08Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹64.75, the stock is trading at a trailing P/E ratio of 4.9x, up from the previous P/E ratio of 4.2x. This compares to an average P/E of 19x in the Chemicals industry in India. Total returns to shareholders over the past three years are 90%.
分析記事 • Jan 03Should You Be Adding Prolife Industries (NSE:PROLIFE) To Your Watchlist Today?Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
Valuation Update With 7 Day Price Move • Dec 18Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹63.50, the stock is trading at a trailing P/E ratio of 4.8x, up from the previous P/E ratio of 4x. This compares to an average P/E of 18x in the Chemicals industry in India. Total returns to shareholders over the past three years are 91%.
Valuation Update With 7 Day Price Move • Dec 02Market bids up stock over the past weekAfter last week's 16% share price gain to ₹43.35, the stock is trading at a trailing P/E ratio of 3.3x, up from the previous P/E ratio of 2.8x. This compares to an average P/E of 16x in the Chemicals industry in India. Total returns to shareholders over the past three years are 12%.
分析記事 • Nov 29Prolife Industries Limited's (NSE:PROLIFE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?Most readers would already be aware that Prolife Industries' (NSE:PROLIFE) stock increased significantly by 18% over...
